This is due to non-operational losses, amounting to $3.5 million as compared to non-operational gains of $0.3 million in FY2022.
HC Surgical Specialists (HCSS) (SGX:1B1
) has reported another year of lower earnings at $2.8 million for its FY2023 ended May 31, a 56.3% decrease from FY2022, as it booked losses from its investments in other listed companies.
Earnings per share fell 56.3% to 1.87 cents from 4.28 cents the previous year, while revenue fell 1.2% to $19.08 million from $19.31 million in FY2022.
